Safety and pharmacokinetics of JNJ-53718678 in healthy adult subjects

Trial Profile

Safety and pharmacokinetics of JNJ-53718678 in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2017

At a glance

  • Drugs JNJ 53718678 (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 14 Mar 2017 New trial record
    • 25 Feb 2017 Results published in the Clinical Pharmacokinetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top